老虎证券

BRIEF-C-Mer Eye Care Sees Adjusted EBITDA To Be Around HK$300 Mln For Year

Reuters
02-06
BRIEF-C-Mer Eye Care Sees Adjusted EBITDA To Be Around HK$300 Mln For Year

Feb 5 (Reuters) - C-Mer Medical Holdings Ltd 3309.HK:

  • SEES ADJUSTED EBITDA TO BE AROUND HK$300 MILLION FOR YEAR

  • SEES REVENUE TO BE AROUND HK$1,900 MILLION IN FY2024

  • EXPECTED RESULT DUE TO WEAKER THAN EXPECTED PERFORMANCE OF CERTAIN HOSPITALS AND CLINICS

  • SEES PROFIT ATTRIBUTABLE TO BE WITHIN HK$50 MILLION TO HK$60 MILLION FOR FY

Further company coverage: 3309.HK

((Reuters.Briefs@thomsonreuters.com;))

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10